Sorbitol Dehydrogenase Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Sorbitol Dehydrogenase monoclonal antibodies for investigating sorbitol dehydrogenase in various biological processes. Sorbitol Dehydrogenase monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Sorbitol dehydrogenase is an essential enzyme involved in the polyol pathway, which converts glucose to sorbitol and subsequently to fructose. The polyol pathway plays a critical role in cellular osmoregulation and is particularly significant in tissues such as the lens of the eye and the kidneys. Dysregulation of sorbitol dehydrogenase has been implicated in various metabolic disorders, including diabetes and its complications. Understanding sorbitol dehydrogenase activity can provide crucial information about cellular metabolism and disease progression. Research utilizing Sorbitol Dehydrogenase monoclonal antibodies has revealed important mechanisms in glucose metabolism and osmotic regulation. Investigating sorbitol dehydrogenase function continues to advance our knowledge of metabolic pathways and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of metabolic disorders and potential therapeutic interventions.